MAULE, MATTEO
MAULE, MATTEO
DIPARTIMENTO DI MEDICINA
Benralizumab Efficacy in Late Non-Responders to Mepolizumab and Variables Associated with Occurrence of Switching: A Real-Word Perspective
2023-01-01 Caminati, Marco; Marcon, Alessandro; Guarnieri, Gabriella; Miotti, Jessica; Bagnasco, Diego; Elisiana Carpagnano, Giovanna; Pelaia, Girolamo; Vaia, Rachele; Maule, Matteo; Vianello, Andrea; Senna, Gianenrico
Biologics for eosinophilic granulomatosis with polyangiitis
2023-01-01 Caminati, Marco; Maule, Matteo; Bello, Federica; Emmi, Giacomo
Comment on: Onset of eosinophilic granulomatosis with polyangiitis in a patient treated with an IL-5 pathway inhibitor for severe asthma: reply
2020-01-01 Caminati, Marco; Maule, Matteo; Nalin, Francesca; Senna, Gianenrico; Lunardi, Claudio
Diagnosis and Management of Allergic Rhinitis in Asthmatic Children
2023-01-01 Tenero, Laura; Vaia, Rachele; Ferrante, Giuliana; Maule, Matteo; Venditto, Laura; Piacentini, Giorgio; Senna, Gianenrico; Caminati, Marco
Hidden Comorbidities in Asthma: A Perspective for a Personalized Approach
2023-01-01 Maule, Matteo; Olivieri, Bianca; Guarnieri, Gabriella; DE FRANCESCHI, Lucia; Martinelli, Nicola; Vaia, Rachele; Argentino, Giuseppe; Vianello, Andrea; Senna, Gianenrico; Caminati, Marco
Low‑dose anti‑IL 5 treatment in idiopathic hypereosinophilic syndrome: towards a precision medicine approach for remission maintenance
2023-01-01 Caminati, Marco; Maule, Matteo; Benoni, Roberto; Micheletto, Claudio; Tecchio, Cristina; Vaia, Rachele; DE FRANCESCHI, Lucia; Guarnieri, Gabriella; Vianello, Andrea; Senna, Gianenrico
Mepolizumab 100 mg in severe asthmatic patients with EGPA in remission phase
2021-01-01 Caminati, Marco; Crisafulli, Ernesto; Lunardi, Claudio; Micheletto, Claudio; Festi, Giuliana; Maule, Matteo; Giollo, Alessandro; Orsolini, Giovanni; Senna, Gianenrico
Onset of eosinophilic granulomatosis with polyangiitis in a patient treated with an IL-5 pathway inhibitor for severe asthma
2020-01-01 Caminati, Marco; Maule, Matteo; Nalin, Francesca; Senna, Gianenrico; Lunardi, Claudio
Profiling severe asthma: Any relevance for age? An analysis from Severe Asthma Network Italy (SANI) cohort
2024-01-01 Caminati, Marco; Marcon, Alessandro; Vaia, Rachele; Senna, Gianenrico; Maule, Matteo; Marchetti, Pierpaolo; Miotti, Jessica; Argentino, Giuseppe; Blasi, Francesco; Canonica, Giorgio W; Heffler, Enrico M; Paggiaro, Pierluigi; Vianello, Andrea; Guarnieri, Gabriella
Reply to "Mepolizumab in patients with eosinophilic granulomatosis with polyangiitis in remission: What is the right dose?"
2021-01-01 Caminati, Marco; Crisafulli, Ernesto; Lunardi, Claudio; Micheletto, Claudio; Festi, Giuliana; Maule, Matteo; Giollo, Alessandro; Orsolini, Giovanni; Senna, Gianenrico
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Benralizumab Efficacy in Late Non-Responders to Mepolizumab and Variables Associated with Occurrence of Switching: A Real-Word Perspective | 1-gen-2023 | Caminati, Marco; Marcon, Alessandro; Guarnieri, Gabriella; Miotti, Jessica; Bagnasco, Diego; Elisiana Carpagnano, Giovanna; Pelaia, Girolamo; Vaia, Rachele; Maule, Matteo; Vianello, Andrea; Senna, Gianenrico | |
| Biologics for eosinophilic granulomatosis with polyangiitis | 1-gen-2023 | Caminati, Marco; Maule, Matteo; Bello, Federica; Emmi, Giacomo | |
| Comment on: Onset of eosinophilic granulomatosis with polyangiitis in a patient treated with an IL-5 pathway inhibitor for severe asthma: reply | 1-gen-2020 | Caminati, Marco; Maule, Matteo; Nalin, Francesca; Senna, Gianenrico; Lunardi, Claudio | |
| Diagnosis and Management of Allergic Rhinitis in Asthmatic Children | 1-gen-2023 | Tenero, Laura; Vaia, Rachele; Ferrante, Giuliana; Maule, Matteo; Venditto, Laura; Piacentini, Giorgio; Senna, Gianenrico; Caminati, Marco | |
| Hidden Comorbidities in Asthma: A Perspective for a Personalized Approach | 1-gen-2023 | Maule, Matteo; Olivieri, Bianca; Guarnieri, Gabriella; DE FRANCESCHI, Lucia; Martinelli, Nicola; Vaia, Rachele; Argentino, Giuseppe; Vianello, Andrea; Senna, Gianenrico; Caminati, Marco | |
| Low‑dose anti‑IL 5 treatment in idiopathic hypereosinophilic syndrome: towards a precision medicine approach for remission maintenance | 1-gen-2023 | Caminati, Marco; Maule, Matteo; Benoni, Roberto; Micheletto, Claudio; Tecchio, Cristina; Vaia, Rachele; DE FRANCESCHI, Lucia; Guarnieri, Gabriella; Vianello, Andrea; Senna, Gianenrico | |
| Mepolizumab 100 mg in severe asthmatic patients with EGPA in remission phase | 1-gen-2021 | Caminati, Marco; Crisafulli, Ernesto; Lunardi, Claudio; Micheletto, Claudio; Festi, Giuliana; Maule, Matteo; Giollo, Alessandro; Orsolini, Giovanni; Senna, Gianenrico | |
| Onset of eosinophilic granulomatosis with polyangiitis in a patient treated with an IL-5 pathway inhibitor for severe asthma | 1-gen-2020 | Caminati, Marco; Maule, Matteo; Nalin, Francesca; Senna, Gianenrico; Lunardi, Claudio | |
| Profiling severe asthma: Any relevance for age? An analysis from Severe Asthma Network Italy (SANI) cohort | 1-gen-2024 | Caminati, Marco; Marcon, Alessandro; Vaia, Rachele; Senna, Gianenrico; Maule, Matteo; Marchetti, Pierpaolo; Miotti, Jessica; Argentino, Giuseppe; Blasi, Francesco; Canonica, Giorgio W; Heffler, Enrico M; Paggiaro, Pierluigi; Vianello, Andrea; Guarnieri, Gabriella | |
| Reply to "Mepolizumab in patients with eosinophilic granulomatosis with polyangiitis in remission: What is the right dose?" | 1-gen-2021 | Caminati, Marco; Crisafulli, Ernesto; Lunardi, Claudio; Micheletto, Claudio; Festi, Giuliana; Maule, Matteo; Giollo, Alessandro; Orsolini, Giovanni; Senna, Gianenrico |